Back
Piedmont Lithium Vs. Keros Therapeutics Industry Stock Comparison
Sell
12
PLL
Piedmont Lithium
Last Price:
9.93
Seasonality Move:
-2.89%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.47
Seasonality Move:
4.22%
Sell
12
Piedmont Lithium (PLL)
is a Sell
Is Piedmont Lithium a Buy, Sell or Hold?
- The current Piedmont Lithium [PLL] share price is $9.31. The Score for PLL is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- PLL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLL Stock Price Chart
What is Piedmont Lithium's stock price today?
-
The Piedmont Lithium share price today is $9.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLL is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
PLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.05 | Sell |
Relative Strength Index (14 RSI): | 23.53 | Sell |
Chaikin Money Flow: | 241195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.6 - 14.4) | Sell |
Bollinger Bands (100): | (11.77 - 14.51) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.91 | Sell |
Relative Strength Index (14 RSI): | 36.74 | Sell |
Chaikin Money Flow: | -120480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.18 - 50.06) | Sell |
Bollinger Bands (100): | (50.42 - 64.92) | Sell |
PLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.38 | Sell |
20-day SMA: | 11.77 | Sell |
50-day SMA: | 12.85 | Sell |
200-day SMA: | 21.35 | Sell |
8-day EMA: | 10.32 | Sell |
20-day EMA: | 11.5 | Sell |
50-day EMA: | 12.69 | Sell |
200-day EMA: | 22.09 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.5 | Sell |
20-day SMA: | 47.57 | Sell |
50-day SMA: | 52.43 | Sell |
200-day SMA: | 46.94 | Sell |
8-day EMA: | 46.46 | Sell |
20-day EMA: | 48 | Sell |
50-day EMA: | 51.59 | Sell |
200-day EMA: | 50.14 | Sell |
Piedmont Lithium Earnings Growth & PLL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.50 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.52 per share, and an increase next year of $4.16 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Piedmont Lithium Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |